Top Story

Stroke risk increases with low-normal TSH levels

September 28, 2016

Patients with thyroid-stimulating hormone levels within the upper limit of the reference range have a lower risk for stroke compared with those whose levels are nearer the lower limit, according to recently published findings.

Robin P. Peeters, MD, PhD, of the Rotterdam Thyroid Center, department of internal medicine, department of epidemiology at Erasmus University Medical Center in the Netherlands, and colleagues collected individual participant data from 17 studies identified through a systematic literature search and the Thyroid Studies Collaboration on 43,598 adults with TSH levels within the 0.45 mIU/L to 4.49 mIU/L reference range. Follow-up was a median of 11.6 years and included 449,908 person-years.

NIH funds trial of chelation therapy for patients with diabetes, prior MI

September 28, 2016
Mount Sinai Medical Center of Florida announced that it and Duke Clinical Research Institute have received an NIH grant of $37 million to fund a second study of IV…
Health Care Legislative and Regulatory Update

Pay careful attention regarding evaluation and management services and the global surgery period

September 28, 2016
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
In the Journals Plus

GLP-1 receptor agonist, DPP-IV inhibitor alter bile acids

September 28, 2016
Liraglutide may alter the intestinal microbiome, whereas sitagliptin may increase hepatic bile acid production in adults with type 2 diabetes, study data show. Mark M
Meeting News Coverage

Obesity rate triples, hypertension rate declines among Brazilian children

September 27, 2016
The rate of obesity among Brazilian school children has tripled in the past 3 decades, rising from 6% in 1986 to 18% in 2016, according to findings from a…
More News Headlines »

Practical Lipidology®: Volume 3, Number 1

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Meeting News Coverage

VIDEO: Less surgery, active surveillance viable option for low-risk thyroid cancer

September 22, 2016
More »
ATA 2016

ATA 2016

CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
in the journals

Get the best of the journals.
Read abstracts, search and filter results, gain perspective, view graphics.

Go »
Current Issues
View the Current Issues